Clinical Trial Update: Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability and efficacy of PresbiDrops (CSF-1) in presbyopic subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• PresbiDrops (CSF-1)

Snippet

Sponsor: Orasis Pharmaceuticals Ltd. | Conditions: Presbyopia | Phase 2 | Status: COMPLETED